Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...

New Singapore law empowers commission to block harmful online content Singapore will introduce a new online safety commission with powers to order social media platforms to block harmful posts, ...